Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1low mice

Blood

Volumn 104, Issue 12, 2004, Pages 3573-3580

  Centurione, Lucia ^b   Di Baldassarre, Angela ^b   Zingariello, Maria ^b   Bosco, Domenico ^b   Gatta, Valentina ^b   Rana, Rosa Alba ^b   Langella, Vincenzo ^b   Di Virgilio, Antonio ^b   Vannucchi, Alessandro M ^b   Migliaccio, Anna Rita ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELOPEROXIDASE; PADGEM PROTEIN; PROTEINASE; TRANSCRIPTION FACTOR GATA 1; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL DEATH; CELL DENSITY; CELL GRANULE; CELL MATURATION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DEMARCATION MEMBRANE SYSTEM; EMPERIPOLESIS; FIBROSIS; GENE MUTATION; MALE; MEGAKARYOCYTE; MEMBRANE STRUCTURE; MICROENVIRONMENT; MOUSE; MYELOFIBROSIS; NEUTROPHIL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

EID: 9244264090     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0193     Document Type: Article

References (38)

1. Italiano JE Jr, Shivdasani RA. Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost. 2003;1:1174-1182.
2. Zucker-Franklin D. Atlas of Blood Cells Function and Pathology. Bologna, Italy: Edi Ermes; 2003.
3. Mahaut-Smith MP, Thomas D, Higham AB, et al. Properties of the demarcation membrane system in living rat megakaryocytes. Biophys J. 2003;84:2646-2654.
4. Schmitt A, Guichard J, Masse JM, et al. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol. 2001;29:1295-1302.
5. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995;86:419-431.
6. Lecine P, Villeval JL, Vyas P, Swencki B, Xu Y, Shivdasani RA. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood. 1998;92:1608-1616.
7. Orkin S. Transcription factors that regulate lineage decisions. In: Stamatoyannopoulos G, Majerus PW, Perlmutter R, Vermus H, eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: Saunders; 2000:80-120.
8. Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 2001;19:397-407.
9. Vyas P, Ault K, Jackson CW, et al. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood. 1999;93:2867-2875.
10. Shivdasani RA, Fujiwara Y, McDevitt MA, et al. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16:3965-3973.
11. Chang AN, Cantor AB, Fujiwara Y, et al. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci U S A. 2002;99:9237-9242.
12. low mice). Blood. 2001;97:3040-3050.
13. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17:2954-2970.
14. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
15. Hoffman R. Agnogenic myeloid metaplasia. In: Hoffman R, Benz EJ, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 2000:1172-1188.
16. Zucker-Franklin D. Ultrastructural studies of hematopoietic elements in relation to the myelofibrosis-osteosclerosis syndrome, megakaryocytes and platelets (MMM or MOS). In: Burkhardt R, Conley CL, Lennert K, Adler SS, Pincus T and Till JE, eds. Dahlem Workshop on Myelofibrosis-Osteosclerosis Syndrome. Vieweg, Germany-West: Pergammon Press; 1975:127-143.
17. Thiele J, Lorenzen J, Manich B, et al. Apoptosis (programmed cell death) in idiopathic (primary) osteo-myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol. 1997;97:137-143.
18. low mice). Blood. 2002;100:1123-1132.
19. Schmitt A, Jouault H, Guichard J, et al. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood. 2000;96:1342-1347.
20. Schmitt A, Drouin A, Masse JM. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis. Leuk Lymphoma. 2002;43:719-724.
21. Bobik R, Dabrowski Z. Emperipolesis of marrow cells within megakaryocytes in the bone marrow of sublethally irradiated mice. Ann Hematol. 1995;70:91-95.
22. Lee KP. Emperipolesis of hematopoietic cells within megakaryocytes in bone marrow of the rat. Vet Pathol. 1989;26:473-478.
23. McGarry MP, Reddington M, Jackson CW. Increased incidence and analysis of emperipolesis in megakaryocytes of the mouse mutant gun-metal. Exp Mol Pathol. 1999;66:191-200.
24. Migliaccio AR, Rana RA, Sanchez M, et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1 low mouse mutant. J Exp Med. 2003;197:281-296.
25. Falcieri E, Bassini A, Pierpaoli S, Luchetti F, et al. Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec. 2000;258:90-99.
26. Kacena MA, Shivdasani RA, Wilson K, et al. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res. 2004;19:652-660.
27. Heijnen HF, Debili N, Vainchencker W, et al. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood. 1998;91:2313-2325.
28. Asher E, Payne CM, Bernstein C. Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electrophoresis, light microscopy and electron microscopy, II: induction of non-classic apoptosis ("para-apoptosis") by tritiated thymidine. Leuk Lymphoma. 1995;19:107-119.
29. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000;97:14376-14381.
30. Houwerzijl EJ, Blom NR, van der Want JJ, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500-506.
31. Denis CV, Andre P, Saffaripour S, et al. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A. 2001;98:4072-4077.
32. Padilla A, Moake JL, Bernardo A, et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004;103:2150-2156.
33. Thiele J, Kuemmel T, Sander C, et al. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia), I: abnormalities of megakaryopoiesis and thrombocytes. J Submicrosc Cytol Pathol. 1991;23:93-107.
34. Cashell AW, Buss DH. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. Ann Hematol. 1992;64:273-276.
35. Toki T, Katuoka, F, Kanezaki R, et al. Transgenic expression of Bach 1 results in megakaryocytic lineage impairment [abstract no. 721 a]. Blood. 2002;100:2843.
36. Chagraoui H, Komura E, Tulliez M, et al. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood. 2002;100:3495-3503.
37. + cell mobilization in idiopathic myelofibrosis [abstract no. 147a]. Blood. 2003;102:504.
38. Subramaniam M, Frenette PS, Saffaripour S, et al. Defects in hemostasis in P-selectin-deficient mice. Blood. 1996;87:1238-1242.